These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32337012)

  • 1. Evaluation of CD160 and CD200 Expression as Differentiating Markers between Chronic Lymphocytic Leukemia and Other Mature B-Cell Neoplasms.
    El-Neanaey WA; Swelem RS; Ghallab OM; Mohamed Abu-Shelou S
    Int J Hematol Oncol Stem Cell Res; 2020 Jan; 14(1):27-37. PubMed ID: 32337012
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination of CD160 and CD200 as a useful tool for differential diagnosis between chronic lymphocytic leukemia and other mature B-cell neoplasms.
    Lesesve JF; Tardy S; Frotscher B; Latger-Cannard V; Feugier P; De Carvalho Bittencourt M
    Int J Lab Hematol; 2015 Aug; 37(4):486-94. PubMed ID: 25470765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of CD200 in differential diagnosis of mature B-cell neoplasm.
    Rahman K; Kumar P; Gupta R; Singh MK; Nityanand S
    Int J Lab Hematol; 2017 Aug; 39(4):384-391. PubMed ID: 28422443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry.
    Sandes AF; de Lourdes Chauffaille M; Oliveira CR; Maekawa Y; Tamashiro N; Takao TT; Ritter EC; Rizzatti EG
    Cytometry B Clin Cytom; 2013 Aug; ():. PubMed ID: 24039011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry.
    Sandes AF; de Lourdes Chauffaille M; Oliveira CR; Maekawa Y; Tamashiro N; Takao TT; Ritter EC; Rizzatti EG
    Cytometry B Clin Cytom; 2014 Mar; 86(2):98-105. PubMed ID: 24243815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD200 is a useful marker in the diagnosis of chronic lymphocytic leukemia.
    Mora A; Bosch R; Cuellar C; Vicente EP; Blanco L; Martino R; Ubeda JM; Sierra J; Moreno C; Nomdedeu J
    Cytometry B Clin Cytom; 2019 Mar; 96(2):143-148. PubMed ID: 30328261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Utility of CD43 and CD200 in Differentiating Chronic Lymphocytic Leukemia from Other Mature B-Cell Neoplasms: A Cross Sectional Study.
    Kannan N; Dass J; Parikh H; Tiwari S; Viswanathan GK; Aggarwal M; Kumar P; Dhawan R; Seth T; Tyagi S; Mahapatra M
    Indian J Hematol Blood Transfus; 2024 Jul; 40(3):437-442. PubMed ID: 39011261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD200 is a useful diagnostic marker for identifying atypical chronic lymphocytic leukemia by flow cytometry.
    Ting YS; Smith SABC; Brown DA; Dodds AJ; Fay KC; Ma DDF; Milliken S; Moore JJ; Sewell WA
    Int J Lab Hematol; 2018 Oct; 40(5):533-539. PubMed ID: 29806244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Diagnostic Usefulness of CD200 Expression in B-cell Chronic Lymphoproliferative Disorders.
    Purohit A; Satiza M; Somasundaram V; Sharma R; Mishra P; Seth T; Tyagi S; Mahapatra M; Pati HP; Saxena R
    Indian J Hematol Blood Transfus; 2023 Oct; 39(4):684-690. PubMed ID: 37786819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent diagnostic utility of CD20, CD200, CD43 and CD45 in chronic lymphocytic leukaemia.
    Ramalingam TR; Mohanraj S; Muthu A; Prabhakar V; Ramakrishnan B; Vaidhyanathan L; Easow J; Raja T
    Leuk Lymphoma; 2022 Feb; 63(2):377-384. PubMed ID: 34676804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD 200 - A useful marker in chronic B lymphoprolipherative disorders.
    Iova A; Vlădăreanu A; Bumbea H; Begu M; Vasile D; Andruş E
    J Med Life; 2012; 5(Spec Issue):66-70. PubMed ID: 31803290
    [No Abstract]   [Full Text] [Related]  

  • 12. [Expression of CD200 in the bone marrow of chronic lymphocytic leukemia patients and its correlations with clinical prognosis].
    Wang X; Zhang Z; Liu Y; Wang L; Yuan H; Xie P; Qu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jan; 30(1):75-8. PubMed ID: 24405602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia.
    Palumbo GA; Parrinello N; Fargione G; Cardillo K; Chiarenza A; Berretta S; Conticello C; Villari L; Di Raimondo F
    Leuk Res; 2009 Sep; 33(9):1212-6. PubMed ID: 19230971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD200 expression in B-cell chronic lymphoproliferative disorders.
    El Desoukey NA; Afify RA; Amin DG; Mohammed RF
    J Investig Med; 2012 Jan; 60(1):56-61. PubMed ID: 22064604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low expression of CD200 predicts shorter time-to-treatment in chronic lymphocytic leukemia.
    Miao Y; Fan L; Wu YJ; Xia Y; Qiao C; Wang Y; Wang L; Hong M; Zhu HY; Xu W; Li JY
    Oncotarget; 2016 Mar; 7(12):13551-62. PubMed ID: 26910908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia.
    D'Arena G; Vitale C; Rossi G; Coscia M; Omedè P; D'Auria F; Statuto T; Valvano L; Ciolli S; Gilestro M; Molica S; Bellesi S; Topini G; Panichi V; Autore F; Innocenti I; Musto P; Deaglio S; Laurenti L; Del Vecchio L
    Hematol Oncol; 2018 Mar; ():. PubMed ID: 29602219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of CD200 in B-cell neoplasms by flow cytometry can assist in diagnosis, subclassification, and bone marrow staging.
    Challagundla P; Medeiros LJ; Kanagal-Shamanna R; Miranda RN; Jorgensen JL
    Am J Clin Pathol; 2014 Dec; 142(6):837-44. PubMed ID: 25389338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD200 and Chronic Lymphocytic Leukemia: Biological and Clinical Relevance.
    D'Arena G; De Feo V; Pietrantuono G; Seneca E; Mansueto G; Villani O; La Rocca F; D'Auria F; Statuto T; Valvano L; Arruga F; Deaglio S; Efremov DG; Sgambato A; Laurenti L
    Front Oncol; 2020; 10():584427. PubMed ID: 33324560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly Sensitive and Accurate Assessment of Minimal Residual Disease in Chronic Lymphocytic Leukemia Using the Novel CD160-ROR1 Assay.
    Farren TW; Sadanand KS; Agrawal SG
    Front Oncol; 2020; 10():597730. PubMed ID: 33344247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression patterns of CD200 and CD148 in leukemic B-cell chronic lymphoproliferative disorders and their potential value in differential diagnosis.
    Fan L; Miao Y; Wu YJ; Wang Y; Guo R; Wang L; Shen AL; Chen YY; Xu W; Li JY
    Leuk Lymphoma; 2015; 56(12):3329-35. PubMed ID: 25791119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.